Attached files

file filename
8-K - 8-K - SYNOPSYS INCd72016d8k.htm

Exhibit 99.1

PRESS RELEASE

INVESTOR CONTACT:

Lisa L. Ewbank

Synopsys, Inc.

650-584-1901

Synopsys-ir@synopsys.com

EDITORIAL CONTACT:

Simone Souza

Synopsys, Inc.

650-584-6454

simone@synopsys.com

Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2020

Q4 FY 2020 Financial Highlights

 

   

Revenue: $1.025 billion

 

   

GAAP earnings per share: $1.26

 

   

Non-GAAP earnings per share: $1.58

FY 2020 Financial Highlights

 

   

Revenue: $3.685 billion

 

   

GAAP earnings per share: $4.27

 

   

Non-GAAP earnings per share: $5.55

 

   

Cash flow from operations: $991.3 million

 

   

Cash and cash equivalents: $1.236 billion

MOUNTAIN VIEW, Calif. Dec. 2, 2020Synopsys, Inc. (Nasdaq: SNPS) today reported results for its fourth quarter and full fiscal year 2020. Revenue for the fourth quarter was $1.025 billion, compared to $851.1 million for the fourth quarter of fiscal year 2019. Revenue for fiscal year 2020 was $3.685 billion, an increase of 9.6 percent from $3.361 billion in fiscal year 2019.

“Synopsys is entering fiscal 2021 with considerable financial, technology and customer momentum as we substantially exceeded our original plan, with excellent growth in revenue, non-GAAP operating margin and earnings, and operating cash flow. Given the unprecedented macro challenges in 2020, it is with particular gratitude that we thank our customers, partners, and the entire Synopsys team for this outcome,” said Aart de Geus, chairman and co-CEO of Synopsys. “Looking forward, market demand is strong, fueled by complex technologies and a multitude of high-profile verticals. Our innovation engine continues to deliver highly advanced capabilities throughout the portfolio. In fiscal 2021, we aim to surpass $4 billion in revenue, with continued non-GAAP operating margin expansion, low-to-mid teens non-GAAP earnings per share growth, and more than $1 billion in operating cash flow.”

 

1


GAAP Results

On a generally accepted accounting principles (GAAP) basis, net income for the fourth quarter of fiscal year 2020 was $197.5 million, or $1.26 per share, compared to $160.7 million, or $1.04 per share, for the fourth quarter of fiscal year 2019. GAAP net income for fiscal year 2020 was $664.3 million, or $4.27 per share, compared to $532.4 million, or $3.45 per share, for fiscal year 2019.

Non-GAAP Results

On a non-GAAP basis, net income for the fourth quarter of fiscal year 2020 was $247.7 million, or $1.58 per share, compared to non-GAAP net income of $177.1 million, or $1.15 per share, for the fourth quarter of fiscal year 2019. Non-GAAP net income for fiscal year 2020 was $864.6 million, or $5.55 per share, compared to non-GAAP net income of $702.5 million, or $4.56 per share, for fiscal year 2019.

For a reconciliation between GAAP and non-GAAP results, see “GAAP to Non-GAAP Reconciliation” and the accompanying tables below.

Business Segments

Synopsys reports revenue and operating income in two segments: (1) Semiconductor & System Design, which includes EDA tools, IP products, system integration solutions and associated services, and (2) Software Integrity, which includes security and quality solutions for software development across many industries. Further information regarding these segments is provided at the end of this press release.

 

2


Financial Targets

Synopsys also provided its consolidated financial targets for the first quarter and full fiscal year 2021. These financial targets assume that there are no changes to the current U.S. government “Entity List” restrictions for the full fiscal year. These targets constitute forward-looking statements and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see “Forward-Looking Statements” below.

First Quarter and Fiscal Year 2021 Financial Targets

(in millions except per share amounts)

 

     Q1 FY 2021     FY 2021  
     Low     High     Low     High  

Revenue

   $ 935     $ 965     $ 4,000     $ 4,050  

GAAP Expenses

   $ 767     $ 785     $ 3,226     $ 3,271  

Non-GAAP Expenses

   $ 674     $ 684     $ 2,825     $ 2,855  

Other Income (Expense)

   $ (2   $ —       $ (11   $ (7

Normalized Annual Tax Rate (1)

     16     16     16     16

Outstanding Shares (fully diluted)

     155       158       156       159  

GAAP EPS

   $ 1.05     $ 1.16     $ 4.39     $ 4.54  

Non-GAAP EPS

   $ 1.44     $ 1.49     $ 6.23     $ 6.30  

Operating Cash Flow

       $ 1,200     $ 1,300  

 

(1)

Applied in non-GAAP net income calculations

Earnings Call Open to Investors

Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys’ corporate website at www.synopsys.com. A recording of the call will be available by calling +1-866-207-1041 (+1-402-970-0847 for international callers), access code 2523787, beginning at 5:00 p.m. Pacific Time today, until 11:59 p.m. Pacific Time on December 9, 2020. A webcast replay will also be available on the website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the first quarter of fiscal year 2021 in February 2021. Synopsys will post copies of the prepared remarks of Aart de Geus, chairman and co-chief executive officer, and Trac Pham, chief financial officer, on its website following today’s call. In addition, Synopsys makes additional information available in a financial supplement and corporate overview presentation, which are also posted on the corporate website.

 

3


Effectiveness of Information

The targets included in this press release, the statements made during the earnings conference call and the information contained in the financial supplement and corporate overview presentation (available in the Investor Relations section of Synopsys’ corporate website at www.synopsys.com) represent Synopsys’ expectations and beliefs as of the date of this release only. Although this press release, copies of the prepared remarks of the co-chief executive officer and chief financial officer made during the call, the financial supplement, and the corporate overview presentation will remain available on Synopsys’ website through the date of the first quarter of fiscal year 2021 earnings call in February 2021, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys does not currently intend to report on its progress during the first quarter of fiscal year 2021 or comment to analysts or investors on, or otherwise update, the targets given in this release.

Availability of Final Financial Statements

Synopsys will include final financial statements for fiscal year 2020 in its annual report on Form 10-K to be filed by December 30, 2020.

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the Silicon to Software partner for innovative companies developing the electronic products and software applications we rely on every day. As the world’s 15th largest software company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and is also growing its leadership in software security and quality solutions. Whether you’re a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing applications that require the highest security and quality, Synopsys has the solutions needed to deliver innovative, high-quality, secure products. Learn more at www.synopsys.com.

GAAP to Non-GAAP Reconciliation

Synopsys continues to provide all information required in accordance with GAAP but believes evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate

 

4


Synopsys’ operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal planning and forecasting purposes. Synopsys’ management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Synopsys’ management believes it is useful for itself and investors to review, as applicable, both GAAP information that includes: (i) the amortization of acquired intangible assets, (ii) the impact of stock compensation, (iii) acquisition-related costs, (iv) restructuring charges, (v) the effects of certain settlements, final judgments and loss contingencies related to legal proceedings, and (vi) the income tax effect of non-GAAP pre-tax adjustments; and the non-GAAP measures that exclude such information in order to assess the performance of Synopsys’ business and for planning and forecasting in subsequent periods.

Synopsys utilizes a normalized annual non-GAAP tax rate in the calculation of its non-GAAP measures to provide better consistency across interim reporting periods by eliminating the effects of non-recurring and period-specific items such as tax audit settlements, which can vary in size and frequency and not necessarily reflect our normal operations, and to more clearly align our tax rate with our expected geographic earnings mix. In projecting this rate, we evaluate our historical and projected mix of U.S. and international profit before tax, excluding the non-GAAP adjustments described above. We also consider other factors including our current tax structure, our existing tax positions, and expected recurring tax incentives. On an annual basis, we re-evaluate this rate for significant events, including changes in tax laws and regulations, that may materially affect our projections. Based upon our review, our projected normalized annual non-GAAP tax rate remains 16% through fiscal year 2021.

Whenever Synopsys uses a non-GAAP financial measure, it provides a reconciliation of the non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed below, as well as Item 2.02 of the Current Report on Form 8-K filed on December 2, 2020 for additional information about the measures Synopsys uses to evaluate its core business operations.

 

5


Reconciliation of Fourth Quarter and Fiscal Year 2020 Results

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income and earnings per share for the periods indicated below.

GAAP to Non-GAAP Reconciliation of Fourth Quarter and Fiscal Year 2020 Results (1)

(unaudited and in thousands, except per share amounts)

 

                                                                           
     Three Months Ended
October 31,
     Twelve Months Ended
October 31,
 
     2020      2019      2020      2019  

GAAP net income

   $  197,455      $ 160,714      $ 664,347      $ 532,367  

Adjustments:

           

Amortization of intangible assets

     21,004        23,776        91,281        100,914  

Stock compensation

     78,429        40,174        248,584        155,001  

Acquisition-related costs

     3,259        1,782        14,096        5,730  

Restructuring charges

     (387      13,440        36,059        47,186  

Legal matters

     —          —          —          (18,000

Tax settlement

     —          —          —          17,418  

Tax adjustments

     (52,084      (62,818      (189,798      (138,093
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP net income

   $ 247,676      $ 177,068      $ 864,569      $ 702,523  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

                                                                           
     Three Months Ended
October 31,
     Twelve Months Ended
October 31,
 
     2020      2019      2020      2019  

GAAP diluted net income per share

   $ 1.26      $ 1.04      $ 4.27      $ 3.45  

Adjustments:

           

Amortization of intangible assets

     0.13        0.15        0.59        0.65  

Stock compensation

     0.50        0.26        1.60        1.01  

Acquisition-related costs

     0.02        0.01        0.08        0.04  

Restructuring charges

     —          0.09        0.23        0.31  

Legal matters

     —          —          —          (0.12

Tax settlement

     —          —          —          0.11  

Tax adjustments

     (0.33      (0.40      (1.22      (0.89
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP diluted net income per share

   $ 1.58      $ 1.15      $ 5.55      $ 4.56  
  

 

 

    

 

 

    

 

 

    

 

 

 

Shares used in computing diluted net income per share amounts:

     156,825        154,532        155,706        154,190  

 

(1)

Synopsys’ fourth quarter of fiscal year 2020 and 2019 ended on October 31, 2020 and November 2, 2019, respectively. For presentation purposes, we refer to the closest calendar month end.

 

6


Reconciliation of Fiscal Year 2021 Targets

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.

GAAP to Non-GAAP Reconciliation of First Quarter Fiscal Year 2021 Targets (1)

(in thousands, except per share amounts)

 

     Range for
Three Months Ending
January 31, 2021
 
     Low      High  

Target GAAP expenses

   $ 767,000      $ 785,000  

Adjustments:

     

Estimated impact of amortization of intangible assets

     (19,000      (22,000

Estimated impact of stock compensation

     (74,000      (79,000
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 674,000      $ 684,000  
  

 

 

    

 

 

 

 

     Range for
Three Months Ending
January 31, 2021
 
     Low      High  

Target GAAP earnings per share

   $ 1.05      $ 1.16  

Adjustments:

     

Estimated impact of amortization of intangible assets

     0.14        0.12  

Estimated impact of stock compensation

     0.50        0.47  

Estimated impact of tax adjustments

     (0.25      (0.26
  

 

 

    

 

 

 

Target non-GAAP earnings per share

   $ 1.44      $ 1.49  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     156,500        156,500  

GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2021 Targets (1)

(in thousands, except per share amounts)

 

     Range for
Fiscal Year Ending
October 31, 2021
 
     Low      High  

Target GAAP expenses

   $ 3,226,000      $ 3,271,000  

Adjustments:

     

Estimated impact of amortization of intangible assets

     (71,000      (76,000

Estimated impact of stock compensation

     (330,000      (340,000
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 2,825,000      $ 2,855,000  
  

 

 

    

 

 

 

 

     Range for
Fiscal Year Ending
October 31, 2021
 
     Low      High  

Target GAAP earnings per share

   $ 4.39      $ 4.54  

Adjustments:

     

Estimated impact of amortization of intangible assets

     0.48        0.45  

Estimated impact of stock compensation

     2.16        2.10  

Estimated impact of tax adjustments

     (0.80      (0.79
  

 

 

    

 

 

 

Target non-GAAP earnings per share

   $ 6.23      $ 6.30  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     157,500        157,500  

 

(1)

Synopsys’ first fiscal quarter and fiscal year will end on January 30, 2021 and October 30, 2021, respectively. For presentation purposes, we refer to the closest calendar month end.

 

7


Forward-Looking Statements

This press release contains forward-looking statements including, but not limited to, statements regarding Synopsys’ short-term and long-term financial targets, expectations and objectives; business outlook, opportunities and strategies; customer demand and market expansion; strategies related to our products and technology; our planned product releases and capabilities; industry growth rates; software trends; planned acquisitions and buybacks; our expected tax rate; the expected impact of U.S. and foreign government action on our results; and the expected impact of the COVID-19 pandemic. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in our forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks from the effect of the COVID-19 pandemic and the associated economic downturn on our business, operations and financial condition; uncertainty in the growth of the semiconductor and electronics industries; consolidation among our customers and our dependence on a relatively small number of large customers; risks and compliance obligations relating to the global nature of our operations as well as actions by the U.S. or foreign governments, such as measures in response to the COVID-19 pandemic or the imposition of additional tariffs or export restrictions; macroeconomic conditions and uncertainty in the global economy; fluctuation of our operating results; increased variability in our revenue due to the adoption of ASC 606, including the resulting increase in recognizing upfront revenue as a percentage of total revenue; and more. Additional information on potential risks, uncertainties and other factors that could affect Synopsys’ results is included in filings it makes with the Securities and Exchange Commission from time to time, including in the sections entitled “Risk Factors” in its Annual Report on Form 10-K for the fiscal year ended October 31, 2019 and its latest Quarterly Report on Form 10-Q. The information provided herein is as of December 2, 2020. Synopsys undertakes no duty, and does not intend to update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

###

 

8


SYNOPSYS, INC.

Unaudited Consolidated Statements of Operations (1)

(in thousands, except per share amounts)

 

     Three Months Ended
October 31,
    Twelve Months Ended
October 31,
 
     2020     2019     2020     2019  

Revenue:

        

Time-based products

   $ 606,598     $ 548,375     $ 2,365,199     $ 2,197,965  

Upfront products

     244,155       168,325       735,572       619,791  

Maintenance and service

     174,686       134,381       584,510       542,938  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenue

     1,025,439       851,081       3,685,281       3,360,694  

Cost of revenue:

        

Products

     142,838       112,964       487,307       459,127  

Maintenance and service

     69,991       56,083       254,931       234,196  

Amortization of intangible assets

     11,720       13,696       52,452       59,623  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenue

     224,549       182,743       794,690       752,946  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     800,890       668,338       2,890,591       2,607,748  

Operating expenses:

        

Research and development

     339,566       290,503       1,279,022       1,136,932  

Sales and marketing

     176,499       161,170       632,010       632,890  

General and administrative

     79,796       63,424       284,530       229,218  

Amortization of intangible assets

     9,284       10,080       38,829       41,291  

Restructuring charges

     (387     13,440       36,059       47,186  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     604,758       538,617       2,270,450       2,087,517  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     196,132       129,721       620,141       520,231  

Other income (expense), net

     (4,095     1,902       18,018       25,275  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     192,037       131,623       638,159       545,506  

Provision (benefit) for income taxes

     (4,989     (29,091     (25,288     13,139  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     197,026       160,714       663,447       532,367  

Net income (loss) attributed to non-controlling interest

     (429     —         (900     —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributed to Synopsys

   $ 197,455     $ 160,714     $ 664,347     $ 532,367  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share:

        

Basic

   $ 1.30     $ 1.07     $ 4.40     $ 3.55  

Diluted

   $ 1.26     $ 1.04     $ 4.27     $ 3.45  

Shares used in computing per share amounts:

        

Basic

     152,349       150,367       151,135       149,872  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

     156,825       154,532       155,706       154,190  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1)

Synopsys’ fourth quarter of fiscal year 2020 and 2019 ended on October 31, 2020 and November 2, 2019, respectively. For presentation purposes, we refer to the closest calendar month end.

 

9


SYNOPSYS, INC.

Unaudited Consolidated Balance Sheets (1)

(in thousands, except par value amounts)

 

     October 31, 2020     October 31, 2019  

ASSETS:

    

Current assets:

    

Cash and cash equivalents

   $ 1,235,653     $ 728,597  

Accounts receivable, net

     780,709       553,895  

Inventories, net

     192,333       141,518  

Income taxes receivable and prepaid taxes

     32,355       24,855  

Prepaid and other current assets

     308,167       290,052  
  

 

 

   

 

 

 

Total current assets

     2,549,217       1,738,917  

Property and equipment, net

     483,818       429,532  

Operating lease right-of-use assets, net

     465,818       —    

Goodwill

     3,365,114       3,171,179  

Intangible assets, net

     254,322       279,374  

Long-term prepaid taxes

     8,276       15,503  

Deferred income taxes

     497,546       390,129  

Other long-term assets

     405,951       380,526  
  

 

 

   

 

 

 

Total assets

   $ 8,030,062     $ 6,405,160  
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY:

    

Current liabilities:

    

Accounts payable and accrued liabilities

   $ 623,664     $ 506,459  

Operating lease liabilities, current

     73,173       —    

Accrued income taxes

     27,738       15,904  

Deferred revenue

     1,388,263       1,212,476  

Short-term debt

     27,084       17,614  
  

 

 

   

 

 

 

Total current liabilities

     2,139,922       1,752,453  

Operating lease liabilities, non-current

     462,411       —    

Long-term accrued income taxes

     25,178       29,911  

Long-term deferred revenue

     104,850       90,102  

Long-term debt

     100,823       120,093  

Other long-term liabilities

     284,511       323,725  
  

 

 

   

 

 

 

Total liabilities

     3,117,695       2,316,284  

Stockholders’ equity:

    

Preferred stock, $ 0.01 par value: 2,000 shares authorized; none outstanding

     —         —    

Common stock, $ 0.01 par value: 400,000 shares authorized; 152,618 and

    

150,331 shares outstanding, respectively

     1,528       1,503  

Capital in excess of par value

     1,653,166       1,635,455  

Retained earnings

     3,795,397       3,164,144  

Treasury stock, at cost: 4,643 and 6,930 shares, respectively

     (488,613     (625,642

Accumulated other comprehensive income (loss)

     (54,074     (92,447
  

 

 

   

 

 

 

Total Synopsys stockholders’ equity

     4,907,404       4,083,013  

Non-controlling interest

     4,963       5,863  
  

 

 

   

 

 

 

Total stockholders’ equity

     4,912,367       4,088,876  
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 8,030,062     $ 6,405,160  
  

 

 

   

 

 

 

 

(1)

Synopsys’ fiscal year 2020 and 2019 ended on October 31, 2020 and November 2, 2019, respectively. For presentation purposes, we refer to the closest calendar month end.

 

10


SYNOPSYS, INC.

Unaudited Consolidated Statements of Cash Flows (1)

(in thousands)

 

     Twelve Months Ended
October 31,
 
     2020     2019  

CASH FLOWS FROM OPERATING ACTIVITIES:

    

Net income attributed to Synopsys

   $ 664,347     $ 532,367  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Amortization and depreciation

     209,986       201,676  

Reduction of operating lease right-of-use assets

     82,895       —    

Amortization of capitalized costs to obtain revenue contracts

     61,185       62,750  

Stock-based compensation

     248,584       155,001  

Allowance for doubtful accounts

     20,875       11,669  

(Gain) loss on sale of property and investments

     (1,994     (4,052

Deferred income taxes

     (111,526     (82,620

Other non-cash

     5,419       (993

Net changes in operating assets and liabilities, net of acquired assets and liabilities:

    

Accounts receivable

     (236,806     (8,575

Inventories

     (55,024     (17,396

Prepaid and other current assets

     (11,298     (49,779

Other long-term assets

     (83,367     (125,749

Accounts payable and accrued liabilities

     113,773       (19,280

Operating lease liabilities

     (78,578     —    

Income taxes

     14,120       19,777  

Deferred revenue

     148,722       125,717  
  

 

 

   

 

 

 

Net cash provided by operating activities

     991,313       800,513  

CASH FLOWS FROM INVESTING ACTIVITIES:

    

Proceeds from sales of long-term investments

     2,151       6,361  

Purchases of long-term investments

     (2,762     (3,245

Purchases of property and equipment

     (154,717     (198,129

Cash paid for acquisitions and intangible assets, net of cash acquired

     (201,045     (36,605

Capitalization of software development costs

     (4,045     (4,259
  

 

 

   

 

 

 

Net cash used in investing activities

     (360,418     (235,877

CASH FLOWS FROM FINANCING ACTIVITIES:

    

Proceeds from credit facilities

     276,489       192,897  

Repayment of debt

     (288,879     (524,063

Issuances of common stock

     197,403       156,364  

Payments for taxes related to net share settlement of equity awards

     (82,225     (57,143

Purchases of treasury stock

     (242,078     (329,185

Other

     (1,316     (762
  

 

 

   

 

 

 

Net cash used in financing activities

     (140,606     (561,892

Effect of exchange rate changes on cash, cash equivalents and restricted cash

     17,154       2,782  
  

 

 

   

 

 

 

Net change in cash, cash equivalents and restricted cash

     507,443       5,526  

Cash, cash equivalents and restricted cash, beginning of year

     730,527       725,001  
  

 

 

   

 

 

 

Cash, cash equivalents and restricted cash, end of period

   $ 1,237,970     $ 730,527  
  

 

 

   

 

 

 

 

(1)

Synopsys’ fiscal year 2020 and 2019 ended on October 31, 2020 and November 2, 2019, respectively. For presentation purposes, we refer to the closest calendar month end.

 

11


SYNOPSYS, INC.

Business Segment Reporting (1)

(in millions)

 

     Q4’20     Q4’19     FY’20     FY’19  

Revenue by segment

        

- Semiconductor & System Design

   $ 934.6     $ 765.8     $ 3,327.2     $ 3,026.1  

% of Total

     91.1     90.0     90.3     90.0

- Software Integrity

   $ 90.8     $ 85.3     $ 358.1     $ 334.6  

% of Total

     8.9     10.0     9.7     10.0

Total segment revenue

   $  1,025.4     $ 851.1     $ 3,685.3     $ 3,360.7  

Adjusted operating income by segment

        

- Semiconductor & System Design

   $ 293.5     $ 202.1     $ 990.8     $ 806.6  

- Software Integrity

   $ 6.2     $ 9.4     $ 40.8     $ 32.2  

Total adjusted segment operating income

   $ 299.7     $ 211.5     $ 1,031.6     $ 838.8  

Adjusted operating margin by segment

        

- Semiconductor & System Design

     31.4     26.4     29.8     26.7

- Software Integrity

     6.8     11.0     11.4     9.6

Total adjusted segment operating margin

     29.2     24.8     28.0     25.0

Total Adjusted Segment Operating Income Reconciliation (1)(2)

(in millions)

 

     Three Months
Ended
October 31, 2020 (3)
    Three Months
Ended
October 31, 2019 (3)
     Twelve Months
Ended
October 31, 2020 (3)
     Twelve Months
Ended
October 31, 2019 (3)
 

GAAP total operating income – as reported

   $ 196.1     $ 129.7      $ 620.1      $ 520.2  

Other expenses managed at consolidated level

          

-Amortization of intangible assets

     21.0       23.8        91.3        100.9  

-Stock compensation

     78.4       40.2        248.6        155.0  

-Fair value changes in executive deferred compensation plan

     1.3       2.6        21.5        27.8  

-Acquisition-related costs

     3.3       1.8        14.1        5.7  

-Restructuring

     (0.4     13.4        36.1        47.2  

-Legal matters

     —         —          —          (18.0
  

 

 

   

 

 

    

 

 

    

 

 

 

Total adjusted segment operating income

   $ 299.7     $ 211.5      $ 1,031.6      $ 838.8  
  

 

 

   

 

 

    

 

 

    

 

 

 

 

(1)

Synopsys manages the business on a long-term, annual basis, and considers quarterly fluctuations of revenue and profitability as normal elements of our business. Quarterly variability, which increases as a result of ASC 606, should be expected. Amounts may not foot due to rounding.

(2)

These segment results are consistent with the information required by ASC 280, Segment Reporting. They are presented to reflect the information that is considered by Synopsys’ chief operating decision makers (CODMs) to evaluate the operating performance of its segments. The CODMs do not allocate certain operating expenses managed at a consolidated level to our reportable segments, and as a result, the reported operating income and operating margin do not include these unallocated expenses as shown in the table above. Amounts may not foot due to rounding.

(3)

Synopsys’ fourth quarter of fiscal year 2020 ended on October 31, 2020, and its fiscal year 2019 ended on November 2, 2019. For presentation purposes, we refer to the closest calendar month end.

 

12